What's new

EMEA-002572-PIP02-19-M03

EMEA-002572-PIP02-19-M03

Jun 26, 2025 - 08:30
 0
EMEA-002572-PIP02-19-M03
EMEA-002572-PIP02-19-M03
Read More

Tags:

Previous Article

Groupe GM développe une ligne solaire pour hôtel avec Hei Poa

Next Article

Developing cancer medicines for children

Related Posts

Orphan designation: Nipocalimab Prevention of fetal and neonatal alloimmune thrombocytopenia Positive

Orphan designation: Nipocalimab Prevention of fetal and...

Jun 10, 2025  0

Human medicines European public assessment report (EPAR): Grepid, clopidogrel, Date of authorisation: 27/07/2009, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 23, 2025  0

Orphan designation: Adeno-associated viral vector serotype 2i8 containing the human LAMP2 isoform B transgene Treatment of Danon disease, 22/05/2025 Positive

Orphan designation: Adeno-associated viral vector serot...

Jun 24, 2025  0